NCT03409731: A reported trial by Abbott Medical Devices
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03409731 |
|---|---|
| Title | Absorb GT1 Bioresorbable Vascular Scaffold (BVS) System Post-marketing Surveillance (PMS) |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Dec. 13, 2016 |
| Completion date | Feb. 6, 2023 |
| Required reporting date | Feb. 6, 2024, midnight |
| Actual reporting date | Dec. 7, 2018 |
| Date last checked at ClinicalTrials.gov | June 3, 2026 |
| Days late | None |